Compare Google Inc (GOOG) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance

Google IncTrade

Regeneron Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Google Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Google Inc trades at $371.24 (market cap $4.52T), while Regeneron Pharmaceuticals Inc trades at $676.02 (market cap $69.66B). The key difference: Google Inc is far larger — about 64.9× Regeneron Pharmaceuticals Inc's market cap, and Regeneron Pharmaceuticals Inc pays the higher dividend (0.57%). Which is the better fit depends on your goals.

	GOOG	REGN
Market Cap	$4.52T	$69.66B
Volume	1,511,127	—
Sector	Technology	Health
52-Week High	$399.06	$812.27
52-Week Low	$183.77	$542.52
Enterprise Value	$4.49T	$63.61B
Dividend Yield	0.24%	0.57%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Google Inc

GOOG trades at $357.33, up 1.9% today, with a bullish technical signal and strong support at $353. The company shows robust fundamentals with 2025 revenue of $402.84B, net income of $132.17B, and a net margin of 32.8%. Recent earnings beats and a consensus analyst price target of $457.50 highlight positive momentum, while news includes Warren Buffett's endorsement and strategic AI partnerships.

Outlook remains positive driven by earnings growth and AI expansion, but risks include regulatory fines and competitive pressures. Wall Street sentiment is strongly bullish with 87% buy ratings, suggesting upside potential, though investors should monitor execution and macroeconomic factors.

Regeneron Pharmaceuticals Inc

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GOOG

Alphabet stock rises on AI, cloud growth, and strong investor backing including Berkshire Hathaway.Tony Dante · 5 hours agoBullish Alphabet stock rises after legal win and Berkshire Hathaway's big investmentTony Dante · 6 hours agoBullish US ITC investigates Samsung and partners for alleged patent infringement on memory products.PRNewsWire · 7 hours agoBearish View details →

REGN

Baird's international and global growth funds underperform MSCI benchmarks in Q2 2026.Seeking Alpha · 2 days agoNeutral View details →

About Google Inc

Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases